Insider Transactions Reported by 10 Insiders of Quoin Pharmaceuticals, Ltd.

Symbol
QNRX on Nasdaq
Location
Kfar Saba

Insiders trading volume in the past year

Quoin Pharmaceuticals, Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stonepine Capital Management, LLC 10%+ Owner $47,201,973 29 Jan 2026
Dennis Langer Director $128,648 +$128,640 +1608000% 04 Feb 2026
Gordon Dunn Chief Financial Officer $67,985 23 Dec 2024
Sally Bridget Lawlor Chief Financial Officer 04 Feb 2026
Sember Michael T. Director 04 Feb 2026
Natalie Ee Mun Leong Director 04 Feb 2026
Michael Myers Chief Executive Officer, Director 04 Feb 2026
Anthony James Culverwell Director 04 Feb 2026
Denise P. Carter Chief Operating Officer, Director 04 Feb 2026
Joseph Patrick Cooper Director 04 Feb 2026

Recent Insider Transactions by Companies or Individuals for Quoin Pharmaceuticals, Ltd.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Sally Bridget Lawlor QNRX Share Option (Right to Buy) Award 85,250 85,250 04 Feb 2026 Direct
Joseph Patrick Cooper QNRX Share Option (Right to Buy) Award 8,141 8,141 04 Feb 2026 Direct
Anthony James Culverwell QNRX Share Option (Right to Buy) Award 21,709 21,709 04 Feb 2026 Direct
Michael Myers QNRX Share Option (Right to Buy) Award 318,750 318,750 04 Feb 2026 Direct
Denise P. Carter QNRX Share Option (Right to Buy) Award 318,750 318,750 04 Feb 2026 Direct
Dennis Langer QNRX Share Option (Right to Buy) Award 21,709 21,709 04 Feb 2026 Direct
Sember Michael T. QNRX Share Option (Right to Buy) Award 8,141 8,141 04 Feb 2026 Direct
Natalie Ee Mun Leong QNRX Share Option (Right to Buy) Award 12,211 12,211 04 Feb 2026 Direct
Sally Bridget Lawlor QNRX Share Option (Right to Buy) Award 10,330 10,330 01 Dec 2025 Direct
Dennis Langer QNRX ADSs Purchase 1515200% $128,640 $8.49 15,152 15,153 14 Oct 2025 Direct
Dennis Langer QNRX Series K Warrants (Right to Buy) Purchase 15,152 15,152 14 Oct 2025 Direct
Dennis Langer QNRX Series J Warrants (Right to Buy) Purchase 15,152 15,152 14 Oct 2025 Direct
Dennis Langer QNRX Series I Warrants (Right to Buy) Purchase 15,152 15,152 14 Oct 2025 Direct
Dennis Langer QNRX Series H Warrants (Right to Buy) Purchase 15,152 15,152 14 Oct 2025 Direct
Natalie Ee Mun Leong QNRX Share Option (Right to Buy) Award 4,105 4,105 21 Aug 2025 Direct
Anthony James Culverwell QNRX Share Option (Right to Buy) Award 13,682 13,682 21 Aug 2025 Direct
Dennis Langer QNRX Share Option (Right to Buy) Award 13,682 13,682 21 Aug 2025 Direct
Denise P. Carter QNRX Share Option (Right to Buy) Award 42,857 42,857 29 May 2025 Direct
Michael Myers QNRX Share Option (Right to Buy) Award 42,857 42,857 29 May 2025 Direct
Anthony James Culverwell QNRX Share Option (Right to Buy) Award 7,760 7,760 29 May 2025 Direct
Natalie Ee Mun Leong QNRX Share Option (Right to Buy) Award 7,760 7,760 29 May 2025 Direct
Dennis Langer QNRX Share Option (Right to Buy) Award 7,760 7,760 29 May 2025 Direct
Joseph Patrick Cooper QNRX Share Option (Right to Buy) Award 7,760 7,760 29 May 2025 Direct
Sember Michael T. QNRX Share Option (Right to Buy) Award 7,760 7,760 29 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.